• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: ECTRIMS 2017

Long-term efficacy, safety of DMTs in MS

December 20, 2017  

Cladribine tablets – Updated efficacy and safety results

November 28, 2017  

ECTRIMS 2017 SLIDE DECK

November 9, 2017  

ECTRIMS 2017 DAILY REPORT – SATURDAY EDITION

October 28, 2017  

ECTRIMS 2017 DAILY REPORT – FRIDAY EDITION

October 27, 2017  

ECTRIMS 2017 DAILY REPORT – THURSDAY EDITION

October 26, 2017  

Browse by Topic

MS (361)
AD (83)
PD (78)
COVID-19 (58)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
BIOMARKERS IN MS (27)
MIGRAINE (26)
SCHIZOPHRENIA (25)
EPILEPSY (22)
STROKE (22)
Library (14)
ECTRIMS 2015 (13)
CLINICAL CASES IN MS (12)
AAN 2015 (11)
ECTRIMS 2014 (10)
ECTRIMS 2019 (10)
ECTRIMS 2021 (10)
DEMENTIA (10)
ECTRIMS 2013 (9)
MS SEQUENCING (9)
AAN 2013 (9)
ECTRIMS 2018 (9)
AAN 2014 (9)
PSYCHIATRY (8)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2019 (7)
CHARCOT 2013 (6)
ECTRIMS 2022 (6)
ECTRIMS 2017 (6)
AAN 2021 (6)
ANXIETY (5)
AAN 2022 (5)
ECTRIMS 2016 (5)
CCSVI (5)
BIPOLAR (5)
BPD (4)
AAN 2023 (4)
NeuroSound (4)
EAN 2015 (4)
EAN 2022 (3)
EAN 2023 (3)
AAN 2017 (3)
AAN 2020 (3)
ENS 2013 (3)
PAIN (3)
NEW DRUGS (2)
APA 2014 (2)
SLEEP (2)
ECTRIMS-ACTRIMS 2023 (2)
EAN 2020 (2)
CMSC 2023 (2)
AAN 2018 (2)
SPECIAL REPORT (2)
ACTRIMS 2023 (1)
GUIDELINES (1)
ACTRIMS 2022 (1)
ECTRIMS (1)
NEWS IN BRIEF (1)
CONCUSSION (1)
LUMBAR PUNCTURE (1)
EAN (1)
EAN 2021 (1)
WEST NILE (1)
AAN 2016 (1)
ALS (1)
LGS (1)
TSC (1)
hATTR (1)
Dravet syndrome (1)
CIDP (1)
ADDICTION (1)
EAN 2019 (1)
APA 2016 (1)
INSOMNIA (1)
SEIZURE (1)
BIOMARKERS (0)
EAN 2016 (0)
ECTRIMS 2020 (0)
AAN (0)
View all Topics

Popular Posts

  • CNS effects of Wegovy (semaglutide) posted on February 28, 2023
  • CLINICAL CASES IN MS – WORSENING SYMPTOMS PRIOR TO OCRELIZUMAB INFUSION posted on September 27, 2023
  • Ofatumumab – update on long-term efficacy, safety posted on September 25, 2023
Copyright 2023 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions